Application 008085

Type
NDA
Sponsor
DAVA PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002METHOTREXATE SODIUMMETHOTREXATE SODIUMTABLET;ORALEQ 2.5MG BASEYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N008085-002METHOTREXATE SODIUMMETHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N008085-002METHOTREXATE SODIUMEQ 2.5MG BASETABLET / ORALRLD, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N008085-002METHOTREXATE SODIUMEQ 2.5MG BASETABLET / ORALRLD, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N008085-002METHOTREXATE SODIUMEQ 2.5MG BASETABLET / ORALABRLD, RS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N008085-002METHOTREXATE SODIUMEQ 2.5MG BASETABLET / ORALRLD, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N008085-002METHOTREXATE SODIUMEQ 2.5MG BASETABLET / ORALRLD, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N008085-002METHOTREXATE SODIUMEQ 2.5MG BASETABLET / ORALABRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N008085-002METHOTREXATE SODIUMEQ 2.5MG BASETABLET / ORALABRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N008085-002METHOTREXATE SODIUMEQ 2.5MG BASETABLET / ORALABRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N008085-002METHOTREXATE SODIUMEQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982e64feba35796…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12N008085-002AB174a2ff9319b5…
2019-12-14 00:12 UTC2019-12N008085-002AB13f01610625f2…
2019-09-15 20:21 UTC2019-09N008085-002AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07N008085-002AB1ea99ee380514…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Methotrexate SodiumMETHOTREXATE SODIUMElite Laboratories, Inc.89c05ea3-3be1-46dd-b112-29c436fd72892026-05-22Boxed warning, Warnings, Adverse reactionsName fallback
brand name: Methotrexate Sodium
generic name: METHOTREXATE SODIUM
MethotrexateMETHOTREXATE SODIUMSun Pharmaceutical Industries, Inc.8f1260de-b60c-4f0e-8af6-0e957b0a281b2026-05-21Boxed warning, Warnings, Adverse reactionsName fallback
generic name: METHOTREXATE SODIUM
Methotrexate SodiumMETHOTREXATE SODIUMHikma Pharmaceuticals USA Inc.d71b1856-99d8-4a9e-9189-f87b6675f80a2026-05-20Boxed warning, Warnings, Adverse reactionsName fallback
brand name: Methotrexate Sodium
generic name: METHOTREXATE SODIUM
MethotrexateMETHOTREXATE SODIUMFresenius Kabi USA, LLCec476b11-0b3c-4139-b1eb-a3daa76bc2712025-08-19Boxed warning, Warnings, Adverse reactionsName fallback
generic name: METHOTREXATE SODIUM
MethotrexateMETHOTREXATE SODIUMBryant Ranch Prepackc7592288-ac24-46c6-8cec-9abe23d7e81e2023-12-07Boxed warning, Warnings, Adverse reactionsName fallback
generic name: METHOTREXATE SODIUM
MethotrexateMETHOTREXATE SODIUMFresenius Kabi USA, LLCb585f621-f6c9-4735-ab61-bd1b401f3df02021-03-24Boxed warning, Adverse reactionsName fallback
generic name: METHOTREXATE SODIUM

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 10 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42254-110METHOTREXATEMETHOTREXATERebel Distributors CorpNDACurrent
50090-0294METHOTREXATEMETHOTREXATEA-S Medication SolutionsNDACurrent
50090-0294METHOTREXATEMETHOTREXATEA-S Medication SolutionsNDACurrent
66336-338METHOTREXATEMETHOTREXATEDispensing Solutions, Inc.NDACurrent
67253-320METHOTREXATEMETHOTREXATEPar PharmaceuticalNDACurrent
67253-320METHOTREXATEMETHOTREXATEPar Pharmaceutical, Inc.NDACurrent
70518-0223METHOTREXATEMETHOTREXATEREMEDYREPACK INC.NDACurrent
70518-0223METHOTREXATEMETHOTREXATEREMEDYREPACK INC.NDACurrent
70518-0223METHOTREXATEMETHOTREXATEREMEDYREPACK INC.NDACurrent
75840-111METHOTREXATE SODIUMMETHOTREXATE SODIUMGenPak Solutions LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
62824SUPPL2020-05-05
62817SUPPL2020-05-05
53061SUPPL2018-03-20
53042SUPPL2018-03-16
32958SUPPL2016-02-18
142SUPPL2016-02-01
141SUPPL2006-06-02
32957SUPPL2003-11-05
32956SUPPL2003-11-05
91SUPPL2003-11-05
89SUPPL2003-11-05
140SUPPL2002-02-20
90SUPPL2002-02-20